The primary intention from the demo was to determine if Anastrozole could prolong the length of “disease-no cost survival” for the collaborating individuals. Disease-cost-free survival is described because the time period after medicines and/or treatments are stopped before the affected individual’s most cancers returns. Through the demo, res